Form 8-K - Current report:
SEC Accession No. 0001753926-25-001055
Filing Date
2025-07-02
Accepted
2025-07-02 17:22:26
Documents
63
Period of Report
2025-07-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K g084856_8k.htm   iXBRL 8-K 149607
2 EXHIBIT 2.2 g084856_ex2-2.htm EX-2.2 14978
3 EXHIBIT 3.1 g084856_ex3-1.htm EX-3.1 31948
4 EXHIBIT 3.2 g084856_ex3-2.htm EX-3.2 27418
5 EXHIBIT 3.3 g084856_ex3-3.htm EX-3.3 250254
6 EXHIBIT 3.4 g084856_ex3-4.htm EX-3.4 74585
7 EXHIBIT 10.6 g084856_ex10-6.htm EX-10.6 346420
8 EXHIBIT 10.7 g084856_ex10-7.htm EX-10.7 10183
9 EXHIBIT 10.8 g084856_ex10-8.htm EX-10.8 273100
10 EXHIBIT 10.9 g084856_ex10-9.htm EX-10.9 141561
11 EXHIBIT 10.10 g084856_ex10-10.htm EX-10.10 72237
12 EXHIBIT 10.11 g084856_ex10-11.htm EX-10.11 33720
13 EXHIBIT 10.12 g084856_ex10-12.htm EX-10.12 319310
14 EXHIBIT 10.13 g084856_ex10-13.htm EX-10.13 324382
15 EXHIBIT 10.14 g084856_ex10-14.htm EX-10.14 150141
16 EXHIBIT 10.15 g084856_ex10-15.htm EX-10.15 57869
17 EXHIBIT 10.16 g084856_ex10-16.htm EX-10.16 59473
18 EXHIBIT 10.17 g084856_ex10-17.htm EX-10.17 89355
19 EXHIBIT 10.18 g084856_ex10-18.htm EX-10.18 91456
20 EXHIBIT 10.19 g084856_ex10-19.htm EX-10.19 90498
21 EXHIBIT 10.20 g084856_ex10-20.htm EX-10.20 67733
22 EXHIBIT 10.21 g084856_ex10-21.htm EX-10.21 112182
23 EXHIBIT 99.1 g084856_ex99-1.htm EX-99.1 16785
24 EXHIBIT 99.2 g084856_ex99-2.htm EX-99.2 20603
25 GRAPHIC img001.jpg GRAPHIC 8428
26 GRAPHIC img002.jpg GRAPHIC 11309
27 GRAPHIC img003.jpg GRAPHIC 3944
28 GRAPHIC img004.jpg GRAPHIC 4622
29 GRAPHIC img005.jpg GRAPHIC 2896
30 GRAPHIC img006.jpg GRAPHIC 2896
31 GRAPHIC img007.jpg GRAPHIC 3944
32 GRAPHIC img008.jpg GRAPHIC 270374
33 GRAPHIC img009.jpg GRAPHIC 139182
34 GRAPHIC img010.jpg GRAPHIC 232756
35 GRAPHIC img011.jpg GRAPHIC 18440
36 GRAPHIC img012.jpg GRAPHIC 21004
37 GRAPHIC img013.jpg GRAPHIC 6100
38 GRAPHIC img014.jpg GRAPHIC 18092
39 GRAPHIC img015.jpg GRAPHIC 6130
40 GRAPHIC img016.jpg GRAPHIC 584130
41 GRAPHIC img017.jpg GRAPHIC 16924
42 GRAPHIC img018.jpg GRAPHIC 16448
43 GRAPHIC img019.jpg GRAPHIC 5885
44 GRAPHIC img020.jpg GRAPHIC 16454
45 GRAPHIC img021.jpg GRAPHIC 5199
46 GRAPHIC img022.jpg GRAPHIC 334002
47 GRAPHIC img023.jpg GRAPHIC 3398
48 GRAPHIC img024.jpg GRAPHIC 6829
49 GRAPHIC img030.jpg GRAPHIC 7440
50 GRAPHIC img031.jpg GRAPHIC 1552
51 GRAPHIC img032.jpg GRAPHIC 1540
  Complete submission text file 0001753926-25-001055.txt   6010320

Data Files

Seq Description Document Type Size
52 XBRL SCHEMA FILE pths-20250701.xsd EX-101.SCH 3268
53 XBRL DEFINITION FILE pths-20250701_def.xml EX-101.DEF 26195
54 XBRL LABEL FILE pths-20250701_lab.xml EX-101.LAB 35951
55 XBRL PRESENTATION FILE pths-20250701_pre.xml EX-101.PRE 24853
65 EXTRACTED XBRL INSTANCE DOCUMENT g084856_8k_htm.xml XML 5542
Mailing Address 685 US HIGHWAY ONE NORTH BRUNSWICK NJ 08902
Business Address 685 US HIGHWAY ONE NORTH BRUNSWICK NJ 08902 9176446313
Pelthos Therapeutics Inc. (Filer) CIK: 0001919246 (see all company filings)

EIN.: 863335449 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41964 | Film No.: 251102609
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)